Loading...

Expanding International Healthcare Access And Efficiencies Will Unlock Value

Published
11 May 25
Updated
16 Aug 25
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-73.8%
7D
-15.8%

Author's Valuation

US$893.1% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on 16 Aug 25

Fair value Decreased 7.69%

Expanding International Healthcare Access And Efficiencies Will Unlock Value

The consensus price target for Lifeward has been revised down to $8.00, primarily reflecting a sharp decrease in its future P/E multiple, while profitability remains stable. What's in the News Lifeward reset full-year 2025 earnings guidance under new management, targeting revenue of $24–$26 million.